Bradda Head  Lithium exceeds targets, secures US$3 million royalty and moves closer to production. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksClose Bros Regulatory News (CBG)

Share Price Information for Close Bros (CBG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 461.00
Bid: 455.80
Ask: 458.00
Change: 45.00 (10.82%)
Spread: 2.20 (0.483%)
Open: 421.80
High: 461.00
Low: 420.40
Prev. Close: 416.00
CBG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Publication of a Prospectus

8 Jun 2021 14:52

RNS Number : 2133B
Close Brothers Group PLC
08 June 2021
 

8 June 2021

NOT FOR DISTRIBUTION IN OR INTO THE UNITED STATES OR ITS TERRITORIES OR TO, OR FOR THE ACCOUNT OR BENEFIT OF, U.S. PERSONS OR OTHERWISE THAN TO PERSONS TO WHOM IT CAN LAWFULLY BE DISTRIBUTED

CLOSE BROTHERS GROUP PLC

PUBLICATION OF PROSPECTUS

The following prospectus has been approved by the Financial Conduct Authority and is available for viewing:

Prospectus dated 8 June 2021 relating to the issue of £200,000,000 2.00% Subordinated Tier 2 Notes by Close Brothers Group plc as issuer (the "Prospectus").

To view the full Prospectus, please paste the following URL into the address bar of your browser:

 

http://www.rns-pdf.londonstockexchange.com/rns/2133B_1-2021-6-8.pdf

The Prospectus will also be available for viewing at the National Storage Mechanism and will shortly be available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism.For further information, please contact:

John HudspithGroup Deputy Company SecretaryClose Brothers Group plcLEI code: 213800W73SYHR14I3X9110 Crown PlaceLondon EC2A 4FT+44 (0) 20 3857 6059

DISCLAIMER - INTENDED ADDRESSEES

Please note that the information contained in the Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Prospectus is not addressed. Prior to relying on the information contained in the Prospectus, you must ascertain from the Prospectus whether or not you are part of the intended addressees of the information contained therein.

In particular, neither this announcement nor the Prospectus shall constitute an offer to sell or the solicitation of an offer to buy securities in the United States or in any other jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration, exemption from registration or qualification under the securities law of any such jurisdiction.

The securities described in the Prospectus have not been and will not be registered under the United States Securities Act of 1933, as amended (the "Securities Act") or any relevant securities laws of any state of the United States. The securities may not be offered or sold within the United States or to or for the account or benefit of U.S. persons except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. The Prospectus may not be accessed from, or transmitted in or into, the United States.

Your right to access this service is conditional upon complying with the above requirements.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PDIXVLFBFQLZBBV
Date   Source Headline
21st Oct 20208:24 amRNSShare Purchase
20th Oct 20204:12 pmRNSDirector/PDMR Shareholding
20th Oct 20209:58 amRNSShare Purchase
19th Oct 202012:02 pmRNSTransaction in Own Shares
16th Oct 20209:05 amRNSNotice of Quarterly Trading Update
16th Oct 20209:00 amRNSAGM Documents
15th Oct 20209:47 amRNSDirector/PDMR Shareholding
12th Oct 202011:42 amRNSDirector/PDMR Shareholding
9th Oct 20205:22 pmRNSHolding(s) in Company
7th Oct 20204:10 pmRNSDirector/PDMR Shareholding
6th Oct 20208:23 amRNSDirector/PDMR Shareholding
5th Oct 20206:14 pmRNSHolding(s) in Company
1st Oct 202010:39 amRNSDirector/PDMR Shareholding
30th Sep 20204:03 pmRNSTotal Voting Rights
28th Sep 20205:00 pmRNSPillar 3 disclosures for year ended 31 July 2020
28th Sep 20204:53 pmRNSAnnual Financial Report
22nd Sep 20207:02 amRNSDirectorate Change
22nd Sep 20207:00 amRNSPreliminary results for the year end 31 July 2020
8th Sep 20203:50 pmRNSDirector/PDMR Shareholding
2nd Sep 202011:48 amRNSTransaction in Own Shares
7th Aug 20208:25 amRNSDirector/PDMR Shareholding
31st Jul 20204:00 pmRNSTotal Voting Rights
22nd Jul 20207:00 amRNSScheduled Trading Update
17th Jul 20201:25 pmRNSHolding(s) in Company
8th Jul 20201:43 pmRNSHolding(s) in Company
7th Jul 202011:45 amRNSDirector/PDMR Shareholding
1st Jul 20204:54 pmRNSTransaction in Own Shares
30th Jun 20204:01 pmRNSTotal Voting Rights
29th Jun 202011:50 amRNSTransaction in Own Shares
23rd Jun 20202:00 pmRNSNotice of Pre-Close Trading Update
22nd Jun 20207:00 amRNSAppointment of Group Chief Executive
9th Jun 202010:37 amRNSHolding(s) in Company
8th Jun 20203:55 pmRNSDirector/PDMR Shareholding
5th Jun 20202:27 pmRNSTransaction in Own Shares
5th Jun 202010:20 amRNSTransaction in Own Shares
29th May 20202:40 pmRNSTotal Voting Rights
22nd May 20207:00 amRNSScheduled Trading Update
21st May 20204:23 pmRNSHolding(s) in Company
15th May 202012:15 pmRNSDirector Declaration
6th May 202011:45 amRNSDirector/PDMR Shareholding
1st May 20206:05 pmRNSDirector/PDMR Shareholding
30th Apr 20205:38 pmRNSBlock Listing Six Monthly Return and Cancellation
30th Apr 20205:37 pmRNSTotal Voting Rights
29th Apr 20204:36 pmRNSDirector/PDMR Shareholding
29th Apr 20203:21 pmRNSTransaction in Own Shares
27th Apr 20203:13 pmRNSDisclosure of rights attached to listed securities
24th Apr 20205:10 pmRNSNotice of Quarterly Trading Update
20th Apr 20201:55 pmRNSHolding(s) in Company
15th Apr 20202:05 pmRNSHolding(s) in Company
8th Apr 20205:23 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.